Follow-up Care After an Emergency Department Visit for Asthma in a Pediatric Military Population: Clinical Interventions and Outcomes

CHEST Journal ◽  
2015 ◽  
Vol 148 (4) ◽  
pp. 674A
Author(s):  
Michael Smiley ◽  
Nick Sicignano ◽  
Elizabeth Allen ◽  
Rees Lee ◽  
Deena Chisolm
Keyword(s):  
Emergency Department ◽  
Emergency Department Visit ◽  
Military Population ◽  
Clinical Interventions ◽  
Follow Up Care

33 Improving Specialty Follow-up Care after an Emergency Department Visit Using a Unique Referral System

2012 ◽  
Vol 60 (4) ◽  
pp. S14
Author(s):  
F.C. Messina ◽  
C. Weaver ◽  
A. Trammel ◽  
M. McDaniel ◽  
D. Ervin ◽  
...  
Keyword(s):  
Emergency Department ◽  
Emergency Department Visit ◽  
Referral System ◽  
Follow Up Care

scholarly journals Initial Emergency Department Visit and Follow-Up Care for Concussions among Children with Medicaid

2019 ◽  
Vol 206 ◽  
pp. 178-183 ◽  
Author(s):  
Anirudh Tarimala ◽  
Bhavna Singichetti ◽  
Honggang Yi ◽  
Lihong Huang ◽  
Rachel Doerschuk ◽  
...  
Keyword(s):  
Emergency Department ◽  
Emergency Department Visit ◽  
Follow Up Care

Refinement of an Instrument to Evaluate Parental Attitudes About Follow-Up Care After an Acute Emergency Department Visit for Asthma

2005 ◽  
Vol 42 (7) ◽  
pp. 587-592 ◽  
Author(s):  
Sharon R. Smith ◽  
Gabrielle R. Highstein ◽  
David M. Jaffe ◽  
Edwin B. Fisher ◽  
Robert C. Strunk
Keyword(s):  
Emergency Department ◽  
Emergency Department Visit ◽  
Parental Attitudes ◽  
Follow Up Care

scholarly journals Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR

10.36469/9905 ◽  
2015 ◽  
Vol 2 (2) ◽  
pp. 221-232
Author(s):  
Mike Durkin ◽  
Jacqueline Pesa ◽  
Jessica Lopatto ◽  
Rachel Halpern ◽  
Damon Van Voorhis ◽  
...  
Keyword(s):  
Emergency Department ◽  
Emergency Department Visit ◽  
Healthcare Costs ◽  
Index Date ◽  
Opioid Therapy ◽  
Care Utilization ◽  
Research Database ◽  
Before And After ◽  
Pain Patients

Background: The objective of this study was to compare health care utilization and costs between matched cohorts of chronic pain patients treated with the opioids tapentadol extended release (ER) or oxycodone controlled release (CR). Methods: This retrospective study used claims data from the Optum Research Database. Commercial and Medicare Advantage adult patients with ≥1 prescription fill for oxycodone CR or tapentadol ER between September 1, 2011 and September 30, 2012 were eligible. The date of the first observed oxycodone CR or tapentadol ER claim was the index date. Patients had continuous health plan enrollment for 6 months before and after the index date, ≥ 90 days supply of opioid therapy, and no index drug claims in the preindex period. Patients were propensity score matched in a 1:2 ratio (tapentadol ER : oxycodone CR). Results: The attributes of the matched cohorts (1,120 tapentadol ER and 2,240 oxycodone CR patients) appeared similar. In the 6 month post-index period, lower proportions of the tapentadol ER cohort than the oxycodone CR cohort had ≥1 inpatient stay (14.6% versus 20.5%; p<0.001) and ≥1 emergency department visit (33.4% versus 37.5%; p=0.021). The tapentadol ER compared with the oxycodone CR cohort had higher mean pharmacy costs ($4,263 versus $3,694; p <0.001), lower mean inpatient costs ($3,625 versus $6,309; p<0.001), and lower mean total healthcare costs ($16,510 versus $19,330; p=0.004). Conclusions: During follow-up, total mean healthcare costs were lower among tapentadol ER patients than oxycodone CR patients, and tapentadol ER patients were less likely to have an inpatient admission or emergency department visit.

Sign in / Sign up

Export Citation Format

Share Document